Association of diabetes with dyskinesia in older psychosis patients

Psychopharmacology

Volumn 176, Issue 3-4, 2004, Pages 281-286

  Caligiuri, Michael P ^a   Jeste, Dilip V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Antipsychotics; Diabetes; Drug induced parkinsonism; Tardive dyskinesia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG INDUCED DISEASE; DYSKINESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; QUANTITATIVE ANALYSIS;

AGED; ANTIPSYCHOTIC AGENTS; COGNITION; DIABETES COMPLICATIONS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; PSYCHOTIC DISORDERS;

EID: 10944220487     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1893-8     Document Type: Article

References (29)

1. Adler CM, Elman I, Weisenfeld N, Kestler L, Pickar D, Breier A (2000) Effects of acute metabolic stress on striatal dopamine release in healthy volunteers. Neuropsychopharmacology 22:545-550
2. Agardh CD, Carlsson A, Linqvist M, Siesjo BK (1979) The effect of pronounced hypoglycemia on monoamine metabolism in rat brain. Diabetes 28:804-809
3. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders 4th edn. APA, Washington D.C.
4. Caligiuri MP, Lohr JB (1991) Fine force instability: a quantitative measure of hand dyskinesia. J Neuropsychiatr Clin Neurosci 2:395-398
5. Caligiuri MP, Lohr JB, Rotrosen J, et al (1997) Reliability of an instrumental measure of tardive dyskinesia: experience of a multicenter study. Psychopharmacology 132:61-66
6. Chang AM, Halter JB (2003) Aging and insulin secretion. Am J Physiol Endocrinol Metab 284:E7-E12
7. Dolder CR, Jeste DV (2003) Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high-risk patients. Biol Psychiatry 5:1142-1145
8. During MJ, Leone P, Davis KE, Kerr D, Sherwi RS (1995) Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 95:2403-2408
9. Folstein MF, Folstein SE, Mchugh PR (1975) "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
10. Ganzini L, Heintz R, Hoffman W, Casey D (1991) The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. Arch Gen Psychiatry 48:259-263
11. Guy W, Psychopharmacology Research Branch, NIMH (1976) Abnormal involuntary movement scale (AIMS), in ECDEU assessment manual for psychopharmacology, revised. Publication ADM 76-338. National Institute of Mental Health, Rockville, pp 534-537
12. Hamilton M (1960) Rating depressive patients. J Clin Psychiatry 41:21-24
13. Ifergane G, Masalha R, Herishanu YO (2001) Transient hemichorea/ hemiballismus associated with new onset hyperglycemia. Can J Neurol Sci 28:365-368
14. Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL, McAdams LA (1995) Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 52:756-765
15. Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP (1999). Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 47:716-719
16. Levin BE (2000) Glucose-regulated dopamine release from substantia nigra neurons. Brain Res 874:158-164
17. Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA (2003) Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 160:290-296
18. Lozoversusky D, Saller CF, Kopin IJ (1981) Dopamine receptor binding is increased in diabetic rats. Science 214:1031-1033
19. Lozoversusky D, Kopin IJ, Saller CF (1985) modulation of dopamine receptor supersensitivity by chronic insulin: implication in schizophrenia. Brain Res 343:190-193
20. Mattis S (1988) Dementia rating scale professional manual. Psychological Assessment Resources, Inc., Odessa, Fla.
21. Mouret J, Khomais M, Lemoine P, Serbet P (1991) Low doses of insulin as a treatment of tardive dyskinesia: conjuncture or conjecture? Eur Neurol 31:199-203
22. Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799-812
23. ATP channels in rat dopaminergic substantia nigra neurons. Pflugers Arch 430:44-54
24. Saller CF (1984) Dopaminergic activity is reduced in diabetic rats. Neurosci Lett 49:301-306
25. Saller CF, Chiodo LA (1980) Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. Science 210:1269-1271
26. Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:486-487
27. Schultz SK, Arndt S, Ho B-C, Oliver SE, Andreasen NC (1999) Impaired glucose tolerance and abnormal movements in patients with schizophrenia. Am J Psychiatry 156:640-642
28. Simpson G, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11-19
29. Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC (2002) The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 63:856-865